Home/Pipeline/MagnetOs Granules

MagnetOs Granules

Instrumented Posterolateral Fusion (PLF)

CommercialMarketed

Key Facts

Indication
Instrumented Posterolateral Fusion (PLF)
Phase
Commercial
Status
Marketed
Company

About Kuros Biosciences

Kuros Biosciences is a commercial-stage orthobiologics company with a mission to address unmet clinical needs for safer, faster, and more predictable bone healing. Its core technology, MagnetOs, is supported by a robust clinical evidence program called Project Fusion, which includes Level I human clinical data demonstrating superior fusion rates compared to autograft. The company leverages a global commercial footprint and strategic advisory boards of leading surgeons to drive adoption of its products in spinal fusion and other orthopedic procedures.

View full company profile